EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Proenkephalin as a Novel Prognostic Marker in Heart Failure Patients: A Systematic Review and Meta-Analysis

Noppachai Siranart iD, Khamik Laohasurayotin, Tanattida Phanthong, Walit Sowalertrat iD, Aekarach Ariyachaipanich, Ronpichai Chokesuwattanaskul iD

International Journal of Molecular Sciences · 03.03.2023 · 24 (5) · 4887

DOI: 10.3390/ijms24054887 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.03.2023. Verfasst von Noppachai Siranart und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok 13300, Thailand. Hauptthemen laut MEDLINE: Heart Failure. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the last several years, the use of biomarkers in the diagnosis of patients with heart failure (HF) has skyrocketed. Natriuretic peptides are currently the most widely used biomarker in the diagnosis and prognosis of individuals with HF. Proenkephalin (PENK) activates delta-opioid receptors in cardiac tissue, resulting in a decreased myocardial contractility and heart rate. However, the goal of this meta-analysis is to evaluate the association between the PENK level at the time of admission and prognosis in patients with HF, such as all-cause mortality, rehospitalization, and decreasing renal function. High PENK levels have been associated with a worsened prognosis in patients with HF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureHumansPrognosisBiomarkersEnkephalinsProtein Precursors

Stichwörter der Autor:innen

heart failuremortalityproenkephalinprognostic markerrehospitalization

Substanzen

BiomarkersproenkephalinEnkephalinsProtein Precursors

Autor:innen und Institutionen

  • Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok 13300, Thailand.
  • Division of Cardiology, Center of Excellence in Arrhythmia Research, Department of Medicine, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok 13300, Th…

ORCID-Profile: Noppachai Siranart, Walit Sowalertrat, Ronpichai Chokesuwattanaskul

Zitieren

APA

Siranart, N., Laohasurayotin, K., Phanthong, T., Sowalertrat, W., Ariyachaipanich, A., & Chokesuwattanaskul, R. (2023). Proenkephalin as a Novel Prognostic Marker in Heart Failure Patients: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences, 24(5), 4887. https://doi.org/10.3390/ijms24054887

Vancouver

Siranart N, Laohasurayotin K, Phanthong T, Sowalertrat W, Ariyachaipanich A, Chokesuwattanaskul R. Proenkephalin as a Novel Prognostic Marker in Heart Failure Patients: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 2023;24(5):4887. doi:10.3390/ijms24054887

BibTeX
@article{Siranart2023,
  author = {Siranart, Noppachai and Laohasurayotin, Khamik and Phanthong, Tanattida and Sowalertrat, Walit and Ariyachaipanich, Aekarach and Chokesuwattanaskul, Ronpichai},
  title = {Proenkephalin as a Novel Prognostic Marker in Heart Failure Patients: A Systematic Review and Meta-Analysis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {5},
  pages = {4887},
  doi = {10.3390/ijms24054887}
}
Kostenlos starten →